What are the challenges and risks associated with nanotechnology in the circulatory system?
Despite its potential, nanotechnology in the circulatory system is not without challenges and risks. One major concern is the toxicity of nanoparticles. Since nanoparticles can interact with biological systems in unforeseen ways, ensuring their safety is crucial. Additionally, the biocompatibility of nanomaterials must be thoroughly evaluated to prevent adverse immune reactions. Regulatory guidelines and ethical considerations also need to be addressed to facilitate the safe and effective use of nanotechnology in medical applications.
